Advances in Functional Imaging of Differentiated Thyroid Cancer

xlomafota13 shared this article with you from Inoreader Advances in Functional Imaging of Differentiated Thyroid Cancer Via radioactive iodine Cancers (Basel). 2021 Sep 23;13(19):4748. doi: 10.3390/cancers13194748. ABSTRACT The present review provides a description of recent advances in the field of functional imaging that takes advantage of the functional characteristics of thyroid neoplastic cells (such as radioiodine uptake and FDG uptake) and theragnostic approach of differentiated thyroid cancer (DTC). Physical and biological characteristics of available radiopharmaceuticals and their use with state-of-the-art technologies for dia gnosis, treatment, and follow-up of DTC patients are depicted. Radioactive iodine is used mostly with a therapeutic intent, while PET/CT with 18F-FDG emerges as a useful tool in the diagnostic management and complements the use of radioactive iodine. Beyond 18F-FDG PET/CT, other tracers including 124I, 18F-TFB and 68Ga-PSMA, and new methods such as PET/MR, might offer new opportunities in selecting patients with DTC for specific imaging modalities or treatments. PMID:34638232 | DOI:10.3390/cancers13194748 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.